Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Hum Pathol. 2016 Jun 24;57:1–6. doi: 10.1016/j.humpath.2016.06.011

Fig. 2.

Fig. 2

Kaplan-Meier estimates of the overall survival (OS) and disease-free survival (DFS) rates of patients with high-grade ovarian serous carcinoma versus those with low-grade ovarian serous carcinoma (P = 0.017 for OS and P = 0.041 for DFS).